Anda, China Health Recent News, Events and Opinion on Allvoices
Front Page

Just In Anda Health News

 
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-04-15 04:51:01 -0700 | health-news

The settlements permit the defendants to begin selling generic versions of Gralise on 1 January 2024, or earlier under certain circumstances...The settlements involve Incepta Pharmaceuticals and Zydus Pharmaceuticals (USA), as well as their affiliated co-defendants.
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-03-13 19:09:15 -0700 | health-news

The solution is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract. IGI Laboratories president and CEO Jason Grenfell-Gardner said the FDA approval marks a...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2011-09-13 09:07:32 -0700 | technology-news

Fondaparinux Sodium Injection is the generic version of GlaxoSmithKline's (GSK) Arixtra which is indicated as a treatment for acute deep vein thrombosis when administered in conjunction with warfarin sodium. The approved doses of the injection include 2.5mg/ 0.5ml, 5.0mg/ 0.4ml,...
Credibility  
Views: 60   News Stories: 1
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2011-04-23 12:50:44 -0700 | technology-news

US Food & Drug Administration (FDA) for calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment, generic forms of Taclonex Ointment. Taclonex ointment is indicated to topically treat psoriasis vulgaris in adults 18 years of age and older.
Credibility  
Views: 22   News Stories: 1
Blog Posts: 0 0 0 0
 

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.